BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
4246797
Number of visits today
414
Number of downloads
3886708
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Guan S, He Y, Su Y, Zhou L. A Risk Signature Consisting of Eight m(6)A Methylation Regulators Predicts the Prognosis of Glioma. Cell Mol Neurobiol 2022;42:2733-43. [PMID: 34432221 DOI: 10.1007/s10571-021-01135-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen P, Xu J, Cui Z, Wu S, Xie T, Zhang X. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1071675] [Reference Citation Analysis]
2 Wu S, Ballah AK, Che W, Wang X. M7G-related LncRNAs: A comprehensive analysis of the prognosis and immunity in glioma. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.961278] [Reference Citation Analysis]
3 Wang Z, Zhong Z, Jiang Z, Chen Z, Chen Y, Xu Y. A novel prognostic 7-methylguanosine signature reflects immune microenvironment and alternative splicing in glioma based on multi-omics analysis. Front Cell Dev Biol 2022;10:902394. [DOI: 10.3389/fcell.2022.902394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345